NCT04567589撤回不适用
A Cross-sectional Study Among Healthcare Professionals in Canada to Assess Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Allergan
- 试验地点
- 1
- 主要终点
- Percentage of HCPs with correct responses to the knowledge level questions.
研究概览
简要总结
This is a non-interventional, cross-sectional survey study to evaluate the effectiveness of the Additional Risk Minimization Measures for Fibristal among Healthcare Professionals (HCPs).
详细描述
Data will be collected via web-based data capture by HCPs submitting surveys. The survey will be conducted in a single wave over 6 months. All data will be maintained in compliance with local regulations.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 接受健康志愿者
- 否
入选标准
- •HCPs have prescribed Fibristal for the indication of uterine fibroids within the past 6 months.
- •HCPs have provided permission to share their responses in aggregate to Health Canada.
排除标准
- •HCPs who participated in the cognitive pre-testing of the survey questionnaire to be used for the study.
- •HCPs who have been direct employees of Allergan, ICON, Health Canada, or Professional Targeted Marketing (PTM) within the past 5 years.
结局指标
主要结局
Percentage of HCPs with correct responses to the knowledge level questions.
时间窗: 18 - 24 months
Correct responses to knowledge-related questions based on the contents of the Fibristal aRMMs.
次要结局
- Percenatage of HCPs that recall distributing the Fibristal Patient Alert Card(18 - 24 months)
- Percentage of HCPs that recall receiving and reading the HCP Letter and HCP Brochure .(18 - 24 months)
- Overall score for each HCP will be calculated that totals the correct responses to all of the knowledge-related questions(18 - 24 months)
- Percentage of patients who recall counselling patients on information included in the Patient Alert Card(18 - 24 months)
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Patients in CanadaUterine FibroidsNCT04567095Allergan
已完成
不适用
A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical PracticeRelapsing Forms of Multiple SclerosisNCT06251986Novartis Pharmaceuticals310
已完成
不适用
An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes PatientsDiabetesNCT02208921AstraZeneca3,000
撤回
不适用
A Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in IndiaHeart FailureNCT02047526AstraZeneca
已完成
不适用
The Study for Evaluating Factors Relating to Daily Step Counts and Physical Activity in Japanese Patients With COPD.Pulmonary Disease, Chronic ObstructiveNCT03642613AstraZeneca505